Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Evidence of small-fiber neuropathy in neurofibromatosis type 1.

Barnett C, Alon T, Abraham A, Kim RH, McCuaig JM, Kongkham P, Maurice C, Suppiah S, Zadeh G, Bril V.

Muscle Nerve. 2019 Dec;60(6):673-678. doi: 10.1002/mus.26687. Epub 2019 Sep 12.

PMID:
31465118
2.

NF1 Patients Receiving Breast Cancer Screening: Insights from The Ontario High Risk Breast Screening Program.

Maani N, Westergard S, Yang J, Scaranelo AM, Telesca S, Thain E, Schachter NF, McCuaig JM, Kim RH.

Cancers (Basel). 2019 May 22;11(5). pii: E707. doi: 10.3390/cancers11050707.

3.

Modified panel-based genetic counseling for ovarian cancer susceptibility: A randomized non-inferiority study.

McCuaig JM, Tone AA, Maganti M, Romagnuolo T, Ricker N, Shuldiner J, Rodin G, Stockley T, Kim RH, Bernardini MQ.

Gynecol Oncol. 2019 Apr;153(1):108-115. doi: 10.1016/j.ygyno.2018.12.027. Epub 2019 Jan 10.

PMID:
30638766
4.

Next-Generation Service Delivery: A Scoping Review of Patient Outcomes Associated with Alternative Models of Genetic Counseling and Genetic Testing for Hereditary Cancer.

McCuaig JM, Armel SR, Care M, Volenik A, Kim RH, Metcalfe KA.

Cancers (Basel). 2018 Nov 13;10(11). pii: E435. doi: 10.3390/cancers10110435. Review.

5.

Additional germline findings from a tumor profiling program.

Stjepanovic N, Stockley TL, Bedard PL, McCuaig JM, Aronson M, Holter S, Semotiuk K, Leighl NB, Jang R, Krzyzanowska MK, Oza AM, Gupta A, Elser C, Ahmed L, Wang L, Kamel-Reid S, Siu LL, Kim RH.

BMC Med Genomics. 2018 Aug 9;11(1):65. doi: 10.1186/s12920-018-0383-5.

6.

Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap.

McCuaig JM, Stockley TL, Shaw P, Fung-Kee-Fung M, Altman AD, Bentley J, Bernardini MQ, Cormier B, Hirte H, Kieser K, MacMillan A, Meschino WS, Panabaker K, Perrier R, Provencher D, Schrader KA, Serfas K, Tomiak E, Wong N, Young SS, Gotlieb WH, Hoskins P, Kim RH; BRCA TtoT Community of Practice.

J Med Genet. 2018 Sep;55(9):571-577. doi: 10.1136/jmedgenet-2018-105472. Epub 2018 Jul 24. Review.

7.

Case Report: Use of Tumor and Germline Y Chromosomal Analysis to Guide Surgical Management in a 46, XX Female Presenting With Gonadoblastoma With Dysgerminoma.

McCuaig JM, Noor A, Rosen B, Casper RF, Mitri F, Colgan T, Kim RH.

Int J Gynecol Pathol. 2017 Sep;36(5):466-470. doi: 10.1097/PGP.0000000000000349.

PMID:
28800577
8.

Prevention of carboplatin-induced hypersensitivity reactions in women with ovarian cancer.

Jerzak KJ, Deghan Manshadi S, Ng P, Maganti M, McCuaig JM, Bulter M, Oza A, Mackay HJ.

J Oncol Pharm Pract. 2018 Mar;24(2):83-90. doi: 10.1177/1078155216679028. Epub 2016 Nov 17.

PMID:
27856924
9.

Routine TP53 testing for breast cancer under age 30: ready for prime time?

McCuaig JM, Armel SR, Novokmet A, Ginsburg OM, Demsky R, Narod SA, Malkin D.

Fam Cancer. 2012 Dec;11(4):607-13. doi: 10.1007/s10689-012-9557-z.

PMID:
22851211
10.

Breast and ovarian cancer: the forgotten paternal contribution.

McCuaig JM, Greenwood CM, Shuman C, Chitayat D, Murphy KJ, Rosen B, Armel SR.

J Genet Couns. 2011 Oct;20(5):442-9. doi: 10.1007/s10897-011-9368-7. Epub 2011 Apr 19.

PMID:
21503821
11.

Breast and ovarian cancer: Y do we forget about dad?

McCuaig JM, Greenwood C, Shuman C, Chitayat D, Murphy KJ, Rosen B, Armel SR.

Lancet Oncol. 2010 Dec;11(12):1115-7. doi: 10.1016/S1470-2045(10)70246-1. No abstract available.

PMID:
20971682

Supplemental Content

Loading ...
Support Center